A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Center for International Blood and Marrow Transplant Research
Sponsor:
Collaborators:
Genzyme, a Sanofi Company
Sanofi
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research
ClinicalTrials.gov Identifier:
NCT01696461
First received: September 24, 2012
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)